Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Delayed Quote. Delayed  - 07/22 05:35:01 pm
92.07 EUR   +0.03%
07/22DJBAYER : 2Q 2016 -- Forecast
07/22 GLOBAL FUNGICID : Industry Study, Insights, Statistics and Research ..
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer AG : Expansion of germplasm-pool for wheat:

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/14/2011 | 11:30am CEST
Bayer CropScience acquires access to wheat germplasm from leading Romanian agricultural research institution
Monheim, October 14, 2011 – Bayer CropScience and the National Agricultural Research and Development Institute (NARDI) in Fundulea/Romania have signed a license agreement. With this agreement, Bayer gains access to winter wheat germplasm of NARDI, the leading Romanian agricultural research institution. Its germplasm pool is renowned world-wide for its winter hardiness, high tolerance against drought, broad disease resistance and good milling and baking quality. Financial details were not disclosed.
“Improving the productivity of wheat cropping will be critical to achieving global food security. Our customers have turned to us to find new ways to help them, we have listened and are building a world-class research platform for wheat genetics. Our agreement with NARDI is another key building block in this strategy“, said Hartmut van Lengerich, Head of Cereals and Fungicides at Bayer CropScience. “To speed up development of new varieties, we have already entered into collaborations with the best partners in wheat research and breeding, reaching from Australia to Israel, France and Ukraine to the United States – and now Romania.”
“Producing enough wheat to feed the world is an immense challenge and anyone willing to invest in the effort to meet this challenge is welcome”, said Marian Verzea, General Director of NARDI. “NARDI is proud that the wheat germplasm developed by its breeding program will be used to speed up genetic progress in breeding better wheat cultivars for other parts of the world, too.”
Key figures about wheat:
With about 25 percent of the global agricultural land under wheat cultivation, it is the largest cereal crop in terms of acreage and one of the world’s most important staple foods. Wheat is the second most-produced cereal crop after corn with more than 650 million tons produced every year. Wheat productivity is increasing at less than 1 percent annually, while the annual global demand is growing at approximately double that percentage. Main wheat producing regions are Australia, the Black Sea Region, China, the EU, India and North America.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
About NARDI
NARDI Fundulea is recognized as the main agricultural research unit in Romania, due to the results obtained in breeding and crop management research & development regarding cereals, industrial and forage crops. Results of wheat breeding have a special place in NARDI’s research portfolio. NARDI’s twenty nine common wheat cultivars released since 1957 have had the largest share of the Romanian wheat seed market for more than 30 years, while nine NARDI wheat cultivars have been released in other countries, such as Canada, Argentina, Hungary, Turkey. Further information is available at: www.incda-fundulea.ro
Find more information at www.bayercropscience.com.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
07/22DJBAYER : 2Q 2016 -- Forecast
07/22 GLOBAL FUNGICIDES MARKET 2016 : Industry Study, Insights, Statistics and Researc..
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBAYER : Holder Broaches Hostile Monsanto Bid -- WSJ
07/20DJBAYER : Investor Floats Idea of Hostile Bid for Monsanto
07/20DJBAYER : Investor Floats Idea of Hostile Bid for Monsanto
07/20 MONSANTO : Views Bayer's Revised Proposal as Financially Inadequate and Insuffic..
07/20DJMONSANTO : Spurns Sweeter Offer -- WSJ
07/20 COVESTRO : shares ‘Chinese innovation’ with the globe
07/20 Monsanto rejects Bayer's sweetened offer, open to talks
More news
Sector news : Pharmaceuticals - NEC
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/21DJBIOGEN : CEO to Step Down; Reports Upbeat Earnings, Outlook--Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/20 Bayer investor floats idea of hostile Monsanto bid
07/19 Warren Buffett Finds A Gem
07/19 Bayer investor seeks shareholder vote on Monsanto deal
07/19 REUTERS : Monsanto, Bayer in talks over confidentiality pact
07/18 REUTERS : Monsanto in talks with Bayer over confidentiality agreement
Advertisement
Financials (€)
Sales 2016 47 216 M
EBIT 2016 8 161 M
Net income 2016 4 672 M
Debt 2016 16 060 M
Yield 2016 2,89%
P/E ratio 2016 16,94
P/E ratio 2017 14,33
EV / Sales 2016 1,95x
EV / Sales 2017 1,81x
Capitalization 76 137 M
More Financials
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 110 €
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Helmut Gunter Wilhelm Panke Member-Supervisory Board
Paul Achleitner Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-20.73%83 560
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.53%219 526
ROCHE HOLDING LTD.-9.55%218 832
MERCK & CO., INC.11.36%162 815
More Results